North America Cardiac Assist Devices Market Share

Statistics for the 2023 & 2024 North America Cardiac Assist Devices market share, created by Mordor Intelligence™ Industry Reports. North America Cardiac Assist Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Cardiac Assist Devices Industry

The North American cardiac assist devices market is highly fragmented in nature, with the presence of many prominent players. Players are focusing on major collaborations, mergers, and acquisitions, in order to enhance their market share. Market players are also focusing on R&D to improve product quality and minimize manufacturing costs. Furthermore, they are developing safer devices to improve patient compliance and safety. Some of the top market players are Abiomed Inc., Abbott Laboratories, Medtronic, Syncardia, and Berlin Heart Gmbh, among others.

North America Cardiac Assist Devices Market Leaders

  1. Abiomed Inc.

  2. Abbott Laboratories

  3. Medtronic

  4. (LivaNova PLC) CardiacAssist Inc.

  5. SynCardia Systems LLC

*Disclaimer: Major Players sorted in no particular order

Abiomed Inc, Abbott Laboratories, Medtronic, (LivaNova PLC) CardiacAssist Inc, SynCardia Systems LLC

North America Cardiac Assist Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)